- Home
- NRO vs DERM Comparison
NRO vs DERM Comparison
Compare NRO & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- DERM
- Stock Information
- Founded
- NRO 2003
- DERM 2014
- Country
- NRO United States
- DERM United States
- Employees
- NRO N/A
- DERM N/A
- Industry
- NRO Finance/Investors Services
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- NRO Finance
- DERM Health Care
- Exchange
- NRO Nasdaq
- DERM Nasdaq
- Market Cap
- NRO 199.6M
- DERM 190.7M
- IPO Year
- NRO N/A
- DERM 2021
- Fundamental
- Price
- NRO $3.20
- DERM $6.98
- Analyst Decision
- NRO
- DERM Strong Buy
- Analyst Count
- NRO 0
- DERM 3
- Target Price
- NRO N/A
- DERM $12.67
- AVG Volume (30 Days)
- NRO 239.4K
- DERM 100.8K
- Earning Date
- NRO 01-01-0001
- DERM 11-11-2025
- Dividend Yield
- NRO 11.41%
- DERM N/A
- EPS Growth
- NRO N/A
- DERM N/A
- EPS
- NRO N/A
- DERM N/A
- Revenue
- NRO N/A
- DERM $56,397,000.00
- Revenue This Year
- NRO N/A
- DERM $26.16
- Revenue Next Year
- NRO N/A
- DERM $45.27
- P/E Ratio
- NRO N/A
- DERM N/A
- Revenue Growth
- NRO N/A
- DERM N/A
- 52 Week Low
- NRO $2.51
- DERM $3.54
- 52 Week High
- NRO $3.45
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- NRO 46.21
- DERM 43.15
- Support Level
- NRO $3.19
- DERM $6.91
- Resistance Level
- NRO $3.25
- DERM $7.79
- Average True Range (ATR)
- NRO 0.04
- DERM 0.32
- MACD
- NRO -0.01
- DERM -0.00
- Stochastic Oscillator
- NRO 38.46
- DERM 15.93
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.